166 related articles for article (PubMed ID: 18480294)
1. Ketamine, but not phencyclidine, selectively modulates cerebellar GABA(A) receptors containing alpha6 and delta subunits.
Hevers W; Hadley SH; Lüddens H; Amin J
J Neurosci; 2008 May; 28(20):5383-93. PubMed ID: 18480294
[TBL] [Abstract][Full Text] [Related]
2. Novel compounds selectively enhance delta subunit containing GABA A receptors and increase tonic currents in thalamus.
Wafford KA; van Niel MB; Ma QP; Horridge E; Herd MB; Peden DR; Belelli D; Lambert JJ
Neuropharmacology; 2009 Jan; 56(1):182-9. PubMed ID: 18762200
[TBL] [Abstract][Full Text] [Related]
3. A Role for GABA
Handforth A; Singh RP; Kosoyan HP; Kadam PA
Tremor Other Hyperkinet Mov (N Y); 2024; 14():20. PubMed ID: 38681506
[TBL] [Abstract][Full Text] [Related]
4.
Sieghart W; Chiou LC; Ernst M; Fabjan J; M Savić M; Lee MT
Pharmacol Rev; 2022 Jan; 74(1):238-270. PubMed ID: 35017178
[TBL] [Abstract][Full Text] [Related]
5. Search for Novel Therapies for Essential Tremor Based on Positive Modulation of α6-Containing GABA
Handforth A; Singh RP; Treven M; Ernst M
Tremor Other Hyperkinet Mov (N Y); 2023; 13():39. PubMed ID: 37900009
[TBL] [Abstract][Full Text] [Related]
6. Ketamine in Trauma: A Literature Review and Administration Guidelines.
Reede K; Bartholomew R; Nielsen D; Ahmeti M; Zreik K
Cureus; 2023 Nov; 15(11):e48099. PubMed ID: 37920424
[TBL] [Abstract][Full Text] [Related]
7. Ketamine preservative benzethonium chloride potentiates hippocampal synaptic transmission and binds neurotransmitter receptors and transporters.
Brown KA; Zanos P; Powels CF; Fix CJ; Michaelides M; Pereira EFR; Moaddel R; Gould TD
Neuropharmacology; 2023 Mar; 225():109403. PubMed ID: 36565852
[TBL] [Abstract][Full Text] [Related]
8. Why Can Modulation of α6-Containing GABA
Sieghart W
Arch Pharmacol Ther; 2024 Jan; 6(1):047. PubMed ID: 38283799
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms underlying differential effectiveness of memantine and ketamine in rapid antidepressant responses.
Gideons ES; Kavalali ET; Monteggia LM
Proc Natl Acad Sci U S A; 2014 Jun; 111(23):8649-54. PubMed ID: 24912158
[TBL] [Abstract][Full Text] [Related]
10. GABA
Agrawal J; Dwivedi Y
Front Neurosci; 2020; 14():600099. PubMed ID: 33240041
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of Muscimol Binding and Gating by Allosteric Modulators of the GABA
Akk G; Germann AL; Sugasawa Y; Pierce SR; Evers AS; Steinbach JH
Mol Pharmacol; 2020 Oct; 98(4):303-313. PubMed ID: 32873746
[TBL] [Abstract][Full Text] [Related]
12. Designer drugs: mechanism of action and adverse effects.
Luethi D; Liechti ME
Arch Toxicol; 2020 Apr; 94(4):1085-1133. PubMed ID: 32249347
[TBL] [Abstract][Full Text] [Related]
13. Overinhibition mediated by parvalbumin interneurons might contribute to depression-like behavior and working memory impairment induced by lipopolysaccharide challenge.
Ji MH; Zhang L; Mao MJ; Zhang H; Yang JJ; Qiu LL
Behav Brain Res; 2020 Apr; 383():112509. PubMed ID: 31987933
[TBL] [Abstract][Full Text] [Related]
14. Drug-selective Anesthetic Insensitivity of Zebrafish Lacking γ-Aminobutyric Acid Type A Receptor β3 Subunits.
Yang X; Jounaidi Y; Mukherjee K; Fantasia RJ; Liao EC; Yu B; Forman SA
Anesthesiology; 2019 Dec; 131(6):1276-1291. PubMed ID: 31567362
[TBL] [Abstract][Full Text] [Related]
15. Flumazenil but not bicuculline counteract the impairing effects of anesthetic ketamine on recognition memory in rats. Evidence for a functional interaction between the GABA
Lafioniatis A; Bermperian VC; Pitsikas N
Neuropharmacology; 2019 Apr; 148():87-95. PubMed ID: 30597159
[TBL] [Abstract][Full Text] [Related]
16. Neonatal inhibition of Na
Stevens RA; Butler BD; Kokane SS; Womack AW; Lin Q
Neurotoxicol Teratol; 2017; 60():82-86. PubMed ID: 27826117
[TBL] [Abstract][Full Text] [Related]
17. Recovery from ketamine-induced amnesia by blockade of GABA-A receptor in the medial prefrontal cortex of mice.
Farahmandfar M; Akbarabadi A; Bakhtazad A; Zarrindast MR
Neuroscience; 2017 Mar; 344():48-55. PubMed ID: 26944606
[TBL] [Abstract][Full Text] [Related]
18. Gene expression changes in GABA(A) receptors and cognition following chronic ketamine administration in mice.
Tan S; Rudd JA; Yew DT
PLoS One; 2011; 6(6):e21328. PubMed ID: 21712993
[TBL] [Abstract][Full Text] [Related]
19. Reversal of ketamine-induced working memory impairments by the GABAAalpha2/3 agonist TPA023.
Castner SA; Arriza JL; Roberts JC; Mrzljak L; Christian EP; Williams GV
Biol Psychiatry; 2010 May; 67(10):998-1001. PubMed ID: 20189164
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
